Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPAIN study of Symbicort SMART versus conventional best practice in adults with persistent asthma
2005-005974-64Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Mar 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of budesonide and formoterol in persistent asthma (2 arms), sponsored by AstraZeneca. Primary endpoint: Time to first severe asthma exacerbation. Started Mar 2006; status: completed.
02
Drugs
budesonideformoterol
03
Conditions
persistent asthma
Beyond the preview
Go deeper on 2005-005974-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005974-64.